Editorial Board Members’ Collection Series: Recent Advancements in Malignant Parotid Tumors
A special issue of Current Oncology (ISSN 1718-7729). This special issue belongs to the section "Head and Neck Oncology".
Deadline for manuscript submissions: closed (30 September 2023) | Viewed by 2281
Special Issue Editors
Interests: head and neck cancer; brain tumor; clinical research; chemotherapy; immunotherapy; target therapy; rare cancer; quality of life; patient centered care
Special Issues, Collections and Topics in MDPI journals
Interests: central venous catheter port; PICC line; superior vena cava syndrome; head and neck cancer; thyroid malignancy; fine needle aspiration cytology; core needle biopsy; thoracic oncology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Salivary gland malignancies are rare, heterogeneous, and diverse, constituting 1–3% of head–neck tumors. Clinical course varies according to a diverse range of histological and clinical behaviors, ranging from indolent, slow-growing adenoid cystic carcinoma to rapidly progressive, possibly fatal, salivary ductal carcinoma.
In this Special Issue on “Editorial Board Members’ Collection Series: Recent Advancements in Malignant Parotid Tumors”, we encourage original research or review articles on the wide range of topics related to parotid tumor, from epidemiology histology and genetic translocation to clinical management, including surgery and radiation therapy, chemotherapy, and novel therapeutics, such as molecular targeted therapies.
Dr. Raffaele Addeo
Dr. Pierre Yves Marcy
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Oncology is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- parotid
- recurrence
- salivary glands
- histology
- molecular biology
- chemotherapy
- radiation therapy
- surgery
- target therapy
